湖北济川药业17.18万份股票期权注销完成

Core Viewpoint - Hubei Jichuan Pharmaceutical Co., Ltd. announced the cancellation of 171,800 stock options due to the departure of certain incentive recipients and failure to meet performance assessments [1] Group 1 - The company held its 17th meeting of the 10th board of directors on September 9, 2025, to review and approve the cancellation of stock options [1] - The cancellation of the stock options has been completed after review and confirmation by the Shanghai branch of China Securities Depository and Clearing Corporation Limited [1] - This cancellation will not affect the company's capital structure or the ongoing implementation of the incentive plan [1]